Literature DB >> 27194757

A Novel Open and Infectious Form of Echovirus 1.

Mira Myllynen1, Artur Kazmertsuk1, Varpu Marjomäki2.   

Abstract

UNLABELLED: One of the hallmarks of enterovirus genome delivery is the formation of an uncoating intermediate particle. Based on previous studies of mostly heated picornavirus particles, intermediate particles were shown to have externalized the innermost capsid protein (VP4) and exposed the N terminus of VP1 and to have reduced infectivity. Here, in addition to the native and intact particle type, we have identified another type of infectious echovirus 1 (E1) particle population during infection. Our results show that E1 is slightly altered during entry, which leads to the broadening of the major virion peak in the sucrose gradient. In contrast, CsCl gradient separation revealed that in addition to the light intact and empty particles, a dense particle peak appeared during infection in cells. When the broad peak from the sucrose gradient was subjected to a CsCl gradient, it revealed light and dense particles, further suggesting that the shoulder represents the dense particle. The dense particle was permeable to SYBR green II, it still contained most of its VP4, and it was able to bind to its receptor α2β1 integrin and showed high infectivity. A thermal assay further showed that the α2β1 integrin binding domain (I-domain) stabilized the virus particle. Finally, heating E1 particles to superphysiological temperatures produced more fragile particles with aberrant ultrastructural appearances, suggesting that they are distinct from the dense E1 particles. These results describe a more open and highly infectious E1 particle that is naturally produced during infection and may represent a novel form of an uncoating intermediate. IMPORTANCE: In this paper, we have characterized a possible uncoating intermediate particle of E1 that is produced in cells during infection. Before releasing their genome into the host cytosol, enteroviruses go through structural changes in their capsid, forming an uncoating intermediate particle. It was shown previously that structural changes can be induced by receptor interactions and, in addition, by heating the native virion to superphysiological temperatures. Here, we demonstrate that an altered, still infectious E1 particle is found during infection. This particle has a more open structure, and it cannot be formed by heating. It still contains the VP4 protein and is able to bind to its receptor and cause infection. Moreover, we show that in contrast to some other enteroviruses, the receptor-virion interaction has a stabilizing effect on E1. This paper highlights the differences between enterovirus species and further increases our understanding of various uncoating forms of enteroviruses.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27194757      PMCID: PMC4944302          DOI: 10.1128/JVI.00342-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

Review 1.  Picornavirus-receptor interactions.

Authors:  Michael G Rossmann; Yongning He; Richard J Kuhn
Journal:  Trends Microbiol       Date:  2002-07       Impact factor: 17.079

2.  Fluorescence labeling of human rhinovirus capsid and analysis by capillary electrophoresis.

Authors:  Leopold Kremser; Tünde Konecsni; Dieter Blaas; Ernst Kenndler
Journal:  Anal Chem       Date:  2004-07-15       Impact factor: 6.986

3.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 4.  Picornavirus entry.

Authors:  Jeffrey M Bergelson; Carolyn B Coyne
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

5.  Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.

Authors:  Ian G Goodfellow; David J Evans; Anna M Blom; Dave Kerrigan; J Scott Miners; B Paul Morgan; O Brad Spiller
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  The structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes.

Authors:  Doryen Bubeck; David J Filman; Naiqian Cheng; Alasdair C Steven; James M Hogle; David M Belnap
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Structural and functional analysis of integrin alpha2I domain interaction with echovirus 1.

Authors:  Li Xing; Mikko Huhtala; Vilja Pietiäinen; Jarmo Käpylä; Kirsi Vuorinen; Varpu Marjomäki; Jyrki Heino; Mark S Johnson; Timo Hyypiä; R Holland Cheng
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

8.  Structural and functional analysis of coxsackievirus A9 integrin αvβ6 binding and uncoating.

Authors:  Shabih Shakeel; Jani J T Seitsonen; Tommi Kajander; Pasi Laurinmäki; Timo Hyypiä; Petri Susi; Sarah J Butcher
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

9.  Permeability changes of integrin-containing multivesicular structures triggered by picornavirus entry.

Authors:  Pan Soonsawad; Lassi Paavolainen; Paula Upla; Wattana Weerachatyanukul; Nina Rintanen; Juan Espinoza; Gregory McNerney; Varpu Marjomäki; R Holland Cheng
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

10.  The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating.

Authors:  Kristin L Shingler; Jennifer L Yoder; Michael S Carnegie; Robert E Ashley; Alexander M Makhov; James F Conway; Susan Hafenstein
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

View more
  7 in total

1.  Extracellular Albumin and Endosomal Ions Prime Enterovirus Particles for Uncoating That Can Be Prevented by Fatty Acid Saturation.

Authors:  Visa Ruokolainen; Aušra Domanska; Mira Laajala; Maria Pelliccia; Sarah J Butcher; Varpu Marjomäki
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

2.  Early Entry Events in Echovirus 30 Infection.

Authors:  Helena Vandesande; Mira Laajala; Tino Kantoluoto; Visa Ruokolainen; A Michael Lindberg; Varpu Marjomäki
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  Slow Infection due to Lowering the Amount of Intact versus Empty Particles Is a Characteristic Feature of Coxsackievirus B5 Dictated by the Structural Proteins.

Authors:  Paula Turkki; Mira Laajala; Marie Stark; Helena Vandesande; Heidi Sallinen-Dal Maso; Sailee Shroff; Anna Sävneby; Ganna Galitska; A Michael Lindberg; Varpu Marjomäki
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

4.  Real-time Fluorescence Measurement of Enterovirus Uncoating.

Authors:  Visa Ruokolainen; Mira Laajala; Varpu Marjomäki
Journal:  Bio Protoc       Date:  2020-04-05

5.  Monolithic anion-exchange chromatography yields rhinovirus of high purity.

Authors:  Günter Allmaier; Dieter Blaas; Christina Bliem; Thomas Dechat; Sofiya Fedosyuk; Irene Gösler; Heinrich Kowalski; Victor U Weiss
Journal:  J Virol Methods       Date:  2017-09-28       Impact factor: 2.014

Review 6.  Antiviral Agents From Fungi: Diversity, Mechanisms and Potential Applications.

Authors:  Riikka Linnakoski; Dhanik Reshamwala; Pyry Veteli; Marta Cortina-Escribano; Henri Vanhanen; Varpu Marjomäki
Journal:  Front Microbiol       Date:  2018-10-02       Impact factor: 5.640

Review 7.  Novel activities of safe-in-human broad-spectrum antiviral agents.

Authors:  Aleksandr Ianevski; Eva Zusinaite; Suvi Kuivanen; Mårten Strand; Hilde Lysvand; Mona Teppor; Laura Kakkola; Henrik Paavilainen; Mira Laajala; Hannimari Kallio-Kokko; Miia Valkonen; Anu Kantele; Kaidi Telling; Irja Lutsar; Pille Letjuka; Natalja Metelitsa; Valentyn Oksenych; Magnar Bjørås; Svein Arne Nordbø; Uga Dumpis; Astra Vitkauskiene; Christina Öhrmalm; Kåre Bondeson; Anders Bergqvist; Tero Aittokallio; Rebecca J Cox; Magnus Evander; Veijo Hukkanen; Varpu Marjomaki; Ilkka Julkunen; Olli Vapalahti; Tanel Tenson; Andres Merits; Denis Kainov
Journal:  Antiviral Res       Date:  2018-04-23       Impact factor: 5.970

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.